Reversion from HBeAg negative to HBeAg positive phenotype after interferon therapy for chronic hepatitis B.

被引：0
|
作者：
Kitis, G [1 ]
Ilias, A [1 ]
Kapetanos, D [1 ]
Kiriazis, G [1 ]
机构：
[1] G Papanikolaou Hosp, Salonika, Greece
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1761
引用
收藏
页码：601A / 601A
页数：1
相关论文
共 50 条
  • [41] Monitoring of HBeAg levels may help to predict the outcomes of lamivudine therapy for HBeAg positive chronic hepatitis B
    Park, NH
    Shin, JW
    Park, JH
    Bang, SJ
    Kim, DH
    Joo, KR
    Kim, DH
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (02) : 216 - 221
  • [42] Treatment of HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Papatheodoridis, GV
    Vassilopoulos, D
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 81 - 88
  • [43] Antiviral treatment of HBeAg positive chronic hepatitis B
    王贵强
    中华肝脏病杂志, 2005, (07) : 540 - 540
  • [44] Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma
    Lin, Shi-Ming
    Yu, Ming-Lung
    Lee, Chuan-Mo
    Chien, Rong-Nan
    Sheen, I-Shyan
    Chu, Chia-Ming
    Liaw, Yun-Fan
    JOURNAL OF HEPATOLOGY, 2007, 46 (01) : 45 - 52
  • [45] Difference of Expression Pattern of Serum Cytokines between HBeAg-positive and HBeAg-negative Chronic Hepatitis B
    He, Dengming
    Li, Maoshi
    Guo, Shimin
    Huang, Hongfei
    Tan, Zhaoxia
    Wang, Yuming
    HEPATOLOGY, 2013, 58 : 416A - 416A
  • [46] Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B
    Arase, Yasnji
    Ikeda, Kenji
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Kobayashi, Masahiro
    Akuta, Norio
    Hosaka, Tetsuya
    Sezaki, Hitomi
    Yatsuji, Hiromi
    Kawamura, Yusuke
    Kobayashi, Mariko
    Kumada, Hiromitsu
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (09) : 1286 - 1292
  • [47] Lack of ethnic differences in response to adefovir dipivoxil therapy in HBeAg+ and HBeAg- patients with chronic hepatitis B.
    Lim, SG
    Marcellin, P
    Tassopoulos, N
    Hadziyannis, S
    Chang, TT
    Tong, M
    Sievert, W
    Hu, P
    Currie, G
    James, C
    Choy, GS
    Kearney, B
    Chen, SS
    Brosgart, CL
    HEPATOLOGY, 2003, 38 (04) : 714A - 715A
  • [48] Clinical & histological outcome of extended lamivudine in patients with HBeAg negative chronic hepatitis B.
    Esteban, R
    Goldin, RD
    Tassopoulos, NC
    Rizzetto, M
    Santantonio, T
    Heathcote, J
    Woessner, M
    Taak, NK
    HEPATOLOGY, 2001, 34 (04) : 446A - 446A
  • [49] The long-term outcome of interferon-alfa treated and untreated patients with HBeAg negative chronic hepatitis B.
    Papatheodoridis, GV
    Manesis, E
    Tsiopou, M
    Papadimitropoulos, V
    Hadziyannis, SJ
    HEPATOLOGY, 1999, 30 (04) : 343A - 343A
  • [50] HBeAg-negative chronic hepatitis B: From obscurity to prominence
    Manesis, Emanuel K.
    JOURNAL OF HEPATOLOGY, 2006, 45 (03) : 343 - 346
12345